Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
BACKGROUND Telerehabilitation involves the delivery of rehabilitation services through communication technologies. In contrast to traditional in-person rehabilitation, telerehabilitation can help overcome barriers including geographic distance and facility use. There is evidence to suggest that telerehabilitation can lead to increased patient engagement and adherence to treatment plans. However, limited research exists on the association of telerehabilitation with adverse events, potentially hindering its broader adoption and utilization in healthcare. OBJECTIVE This systematic review of randomized controlled trials aims to summarize existing research on adverse events related to telerehabilitation delivery. METHODS This review was conducted according to the methodological framework outlined by the Joanna Briggs Institute. Studies were identified from MEDLINE ALL, EMBASE, APA PsycINFO, CENTRAL, and CINAHL. Included studies were randomized controlled trials published between 2013 and 2023, written in English, and had no geographic or delivery mode restrictions. Data extraction utilized the Template for Intervention Description and Replication (TIDieR) framework, along with authors, publication year, sample size, specific telerehabilitation modes, and the incidence, type, severity, and relatedness of reported adverse events. Methodological quality was assessed using the Cochrane risk of bias tool. RESULTS Search results identified 9,022 references, of which 37 randomized controlled trials met the criteria for inclusion. There were a total of 3,166 participants, with a mean age of 57.4 years, and 32.3% being female. Various delivery modes were utilized, with videoconferencing emerging as the most frequently employed method. A total of 201 adverse events were recorded during 65,352 sessions (0.31% or 3.1/1000 sessions). These events were predominantly physical (e.g., falls, palpitations), non-serious/mild, and not directly attributed to the telerehabilitation intervention. Additionally, 92.2% of included studies implemented various safety practices including vital signs monitoring, safety checklists, and scheduled check-ins with study personnel. CONCLUSIONS This review demonstrates that telerehabilitation exhibits a generally safe profile as an alternative to in-person rehabilitation, with most reported adverse events being rare, non-serious/mild, and unrelated to telerehabilitation protocols. However, more extensive research with detailed reporting on adverse events characteristics is needed. Moreover, future research should evaluate the effectiveness of different safety practices and their association with adverse events. An enhanced understanding of potential risks in telerehabilitation can foster broader adoption while ensuring its safe implementation among healthcare providers and patients.
BACKGROUND Telerehabilitation involves the delivery of rehabilitation services through communication technologies. In contrast to traditional in-person rehabilitation, telerehabilitation can help overcome barriers including geographic distance and facility use. There is evidence to suggest that telerehabilitation can lead to increased patient engagement and adherence to treatment plans. However, limited research exists on the association of telerehabilitation with adverse events, potentially hindering its broader adoption and utilization in healthcare. OBJECTIVE This systematic review of randomized controlled trials aims to summarize existing research on adverse events related to telerehabilitation delivery. METHODS This review was conducted according to the methodological framework outlined by the Joanna Briggs Institute. Studies were identified from MEDLINE ALL, EMBASE, APA PsycINFO, CENTRAL, and CINAHL. Included studies were randomized controlled trials published between 2013 and 2023, written in English, and had no geographic or delivery mode restrictions. Data extraction utilized the Template for Intervention Description and Replication (TIDieR) framework, along with authors, publication year, sample size, specific telerehabilitation modes, and the incidence, type, severity, and relatedness of reported adverse events. Methodological quality was assessed using the Cochrane risk of bias tool. RESULTS Search results identified 9,022 references, of which 37 randomized controlled trials met the criteria for inclusion. There were a total of 3,166 participants, with a mean age of 57.4 years, and 32.3% being female. Various delivery modes were utilized, with videoconferencing emerging as the most frequently employed method. A total of 201 adverse events were recorded during 65,352 sessions (0.31% or 3.1/1000 sessions). These events were predominantly physical (e.g., falls, palpitations), non-serious/mild, and not directly attributed to the telerehabilitation intervention. Additionally, 92.2% of included studies implemented various safety practices including vital signs monitoring, safety checklists, and scheduled check-ins with study personnel. CONCLUSIONS This review demonstrates that telerehabilitation exhibits a generally safe profile as an alternative to in-person rehabilitation, with most reported adverse events being rare, non-serious/mild, and unrelated to telerehabilitation protocols. However, more extensive research with detailed reporting on adverse events characteristics is needed. Moreover, future research should evaluate the effectiveness of different safety practices and their association with adverse events. An enhanced understanding of potential risks in telerehabilitation can foster broader adoption while ensuring its safe implementation among healthcare providers and patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.